Literature DB >> 2707636

Disability from inflammatory bowel disease among employees in West Germany.

A Sonnenberg1.   

Abstract

The statistics of the German social security system were used to analyse the epidemiology of inflammatory bowel disease (IBD) in Germany and to assess its impact on disability. Patients granted disability pension for IBD were compared with a control group of patients disabled from other causes. Crohn's disease and ulcerative colitis led to disability in significantly younger patients than other diseases. Disability from Crohn's disease was 2.0-fold more common in women than men (95% confidence interval: 1.8-2.3), while disability from ulcerative colitis was similar in both sexes. White collar employees were affected by both diseases more frequently than blue collar employees, the ratio being 1.3 (1.2-1.5) in Crohn's disease and 1.6 (1.4-1.8) in ulcerative colitis. Although IBD is relatively rare, it has severe socioeconomic implications, because compared with other diseases, predominantly young age groups become disabled.

Entities:  

Mesh:

Year:  1989        PMID: 2707636      PMCID: PMC1378460          DOI: 10.1136/gut.30.3.367

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Ulcerative colitis in the United States Army in 1944. Epidemiology: comparisons between patients and controls.

Authors:  E D ACHESON; M D NEFZGER
Journal:  Gastroenterology       Date:  1963-01       Impact factor: 22.682

2.  Incidence of Crohn's disease in a defined population in northern Sweden, 1974-1981.

Authors:  H Nyhlin; A Danielsson
Journal:  Scand J Gastroenterol       Date:  1986-12       Impact factor: 2.423

3.  Incidence and prevalence of ulcerative colitis in the Jewish population of Jerusalem.

Authors:  W Z Jacobsohn; Y Levine
Journal:  Isr J Med Sci       Date:  1986 Jul-Aug

4.  Epidemiology of ulcerative colitis and regional enterocolitis (Crohn's disease) in Norway.

Authors:  J Myren; E Gjone; J N Hertzberg; O Rygvold; L S Semb; B Fretheim
Journal:  Scand J Gastroenterol       Date:  1971       Impact factor: 2.423

5.  Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982.

Authors:  J H Gollop; S F Phillips; L J Melton; A R Zinsmeister
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

6.  Trends in incidence rates of ulcerative colitis and Crohn's disease.

Authors:  B M Calkins; A M Lilienfeld; C F Garland; A I Mendeloff
Journal:  Dig Dis Sci       Date:  1984-10       Impact factor: 3.199

7.  Incidence of ulcerative colitis in Stockholm County 1955-1979.

Authors:  B Nordenvall; O Broström; M Berglund; U Monsen; J Nordenström; J Sörstad; G Hellers
Journal:  Scand J Gastroenterol       Date:  1985-09       Impact factor: 2.423

8.  Crohn's disease in Blackpool--incidence and prevalence 1968-80.

Authors:  F I Lee; F T Costello
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

9.  Chronic ulcerative colitis: incidence and prevalence in a community.

Authors:  C M Stonnington; S F Phillips; L J Melton; A R Zinsmeister
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

10.  Ulcerative colitis in the Jewish population of southern Israel 1961-1985: epidemiological and clinical study.

Authors:  H S Odes; D Fraser; J Krawiec
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

View more
  16 in total

1.  Tailoring the treatment to the individual in Crohn's disease.

Authors:  Edouard Louis; Jacques Belaiche; Catherine Reenaers
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

2.  IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study.

Authors:  Alexis Ramos; Xavier Calvet; Beatriz Sicilia; Mercedes Vergara; Ariadna Figuerola; Jaume Motos; Adoración Sastre; Albert Villoria; Fernando Gomollón
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

Review 3.  Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature.

Authors:  Natasha-A Koloski; Laurel Bret; Graham Radford-Smith
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

Review 4.  The pharmacoeconomics of biologic therapy for IBD.

Authors:  Russell D Cohen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02       Impact factor: 46.802

5.  The socio-economic impact of work disability due to inflammatory bowel disease in Brazil.

Authors:  Renata de S B Fróes; Ana Teresa Pugas Carvalho; Antonio Jose de V Carneiro; Adriana Maria Hilu de Barros Moreira; Jessica P L Moreira; Ronir R Luiz; Heitor S de Souza
Journal:  Eur J Health Econ       Date:  2017-05-18

6.  Circadian Rhythm Disruption Aggravates DSS-Induced Colitis in Mice with Fecal Calprotectin as a Marker of Colitis Severity.

Authors:  Joseph Amara; Youakim Saliba; Joelle Hajal; Viviane Smayra; Jules-Joel Bakhos; Raymond Sayegh; Nassim Fares
Journal:  Dig Dis Sci       Date:  2019-05-21       Impact factor: 3.199

Review 7.  Sleep and Fatigue in IBD: an Unrecognized but Important Extra-intestinal Manifestation.

Authors:  Andrew Canakis; Taha Qazi
Journal:  Curr Gastroenterol Rep       Date:  2020-01-30

8.  Recombinant human MFG-E8 ameliorates colon damage in DSS- and TNBS-induced colitis in mice.

Authors:  Yinzhong Zhang; Max Brenner; Weng-Lang Yang; Ping Wang
Journal:  Lab Invest       Date:  2015-03-09       Impact factor: 5.662

9.  Occupational distribution of inflammatory bowel disease among German employees.

Authors:  A Sonnenberg
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 10.  Cost of illness of Crohn's disease.

Authors:  Keith Bodger
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.